Ovid Therapeutics, Inc. (OVID)
1.42
-0.08
(-5.33%)
USD |
NASDAQ |
Feb 13, 16:00
1.42
0.00 (0.00%)
After-Hours: 18:38
Ovid Therapeutics Free Cash Flow : -37.93M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ionis Pharmaceuticals, Inc. | -309.48M |
| Cassava Sciences, Inc. | -83.91M |
| AnaptysBio, Inc. | -145.42M |
| Cogent Biosciences, Inc. | -246.73M |
| Lyell Immunopharma, Inc. | -165.54M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.87M |
| Cash from Investing (Quarterly) | 5.053M |
| Cash from Financing (Quarterly) | 0.015M |
| Free Cash Flow Per Share (Quarterly) | -0.181 |
| Free Cash Flow to Equity (Quarterly) | -12.54M |
| Free Cash Flow to Firm (Quarterly) | -12.87M |
| Free Cash Flow Yield | -37.58% |